23 24 25 26 Flexible C-terminal phosphorylation deactivates melanopsin 2 27 ABSTRACT 28 Melanopsin is a visual pigment expressed in a small subset of ganglion cells in the mammalian 29 retina known as intrinsically photosensitive retinal ganglion cells (ipRGCs) and is implicated in regulating 30 non-image forming functions such as circadian photoentrainment and pupil constriction and contrast 31 sensitivity in image formation. Mouse melanopsin's Carboxy-terminus (C-terminus) possesses 38 serine 32 and threonine residues, which can potentially serve as phosphorylation sites for a G-protein Receptor 33 Kinase (GRK) and be involved in the deactivation of signal transduction. Previous studies suggest that 34 S388, T389, S391, S392, S394, S395 on the proximal region of the C-terminus of mouse melanopsin are 35 necessary for melanopsin deactivation. We expressed a series of mouse melanopsin C-terminal mutants in 36 HEK293 cells and using calcium imaging, and we found that the necessary cluster of six serine and 37 threonine residues, while being critical, are insufficient for proper melanopsin deactivation. Interestingly, 38 the additional six serine and threonine residues adjacent to the required six sites, in either proximal or distal 39 direction, are capable of restoring wild-type deactivation of melanopsin. These findings suggest an element 40 of plasticity in the molecular basis of melanopsin phosphorylation and deactivation. In addition, C-terminal 41 chimeric mutants and molecular modeling studies support the idea that the initial steps of deactivation and 42 β-arrestin binding are centered around these critical phosphorylation sites (S388-S395). This degree of 43 functional versatility could help explain the diverse ipRGC light responses as well as non-image and image 44 forming behaviors, even though all six sub types of ipRGCs express the same melanopsin gene OPN4. 45 46
forming processes such as light-induced pupil constriction, circadian photoentrainment, and sleep (4, 2).
55
Based on sequence homology, melanopsin is more closely related to visual pigments found in rhabdomeric 56 photoreceptors found in organisms such as Drosophila (5, 1). Specifically, mouse melanopsin shares 27% 57 amino acid sequence identity with mouse rhodopsin, a ciliary (C-type) opsin while sharing 31.5% identity 58 with squid rhodopsin, a rhabdomeric (R-type) opsin. Thus, melanopsin is predicted to function and signal 59 in a manner distinct from mammalian visual pigments expressed in rod and cone photoreceptors. Compared kinetics, compared to rod and cone photoreceptor cells.
68
In M1-type ipRGCs, light-activated melanopsin is proposed to couple to Gαq/11 (9, 10, 11), which 69 activates PLCβ4 that ultimately results in a depolarization of the cell. Previous studies suggest that 70 melanopsin signaling desensitization is initiated by G protein-coupled Receptor Kinase (GRK)-mediated 71 C-terminal phosphorylation (12, 13, 14, 15) which stimulates β-arrestin binding (16, 17). However, there 72 is evidence suggesting that GRK2-mediated phosphorylation is not critical in ipRGCs (18), and other 73 studies also suggest that melanopsin phosphorylation can be mediated by alternate kinases such as Protein
74
Kinase C (19) , S6K1 (19) , and Protein Kinase A (20). These data suggest diverse molecular regulation of 75 melanopsin phosphorylation, unlike the canonical GRK-mediated phosphorylation of GPCRs. Additional 76 analysis of mouse melanopsin deactivation via calcium assays in tissue culture cells suggests that a cluster 77 of six C-terminal residues, S388, T389, S391, S392, S394, S395, are required to deactivate melanopsin 78 signaling (13), and similar mutagenesis of C-terminal phosphorylation sites, S381, S384, T385, S388, T389, 
85
Melanopsin's C-terminus is unique amongst mammalian opsins. It is 171 amino acids long and 86 comprises 38 serine and threonine residues ( Figure 1 ), which are potential sites for phosphorylation. This
87
contrasts with the C-terminus of the image-forming visual pigment rhodopsin, which is 39 amino acids long 88 and has 8 possible sites for phosphorylation. Mass spectrometric analysis of rhodopsin suggests site-specific 89 phosphorylation of its C-terminus at three serine and threonine residues in response to light (21, 22, 23, 24, 90 25). A similar number of phosphorylations was reported in the neuropeptide FF2 receptor (26), and up to 91 six phosphorylation sites were identified in the β2-adrenergic receptor (27, 28, 29). Here, we hypothesize 92 that the proper function of mouse melanopsin's C-terminus during deactivation requires a larger bulk 93 negative charge due to more serine and threonine phosphorylations than in opsins expressed in rod and cone 94 photoreceptors. This requirement for extra phosphorylation sites in the C-terminus may contribute to 95 melanopsin's sustained and slow light response. We found that a bulk negative charge on melanopsin's C-
96
terminus is centered at P-II (The second cluster of putative C-terminal phosphorylation sites, see Figure 1 ) 97 on the proximal region, but neighboring serine and threonine residues are necessary and capable of 98 contributing to melanopsin deactivation as well. This suggests a unique level of flexibility in the capability 99 of melanopsin's C-terminus to regulate signaling deactivation through phosphorylation, and this property 100 paves the way to understanding the unique signaling kinetics of the ipRGC. 
103
Serine and threonine residues are represented by colored circles. Clusters of six putative phosphorylation 104 sites of interest, denoted as P-I, P-II, P-III, P-IV, are in different colors. The proximal C-terminus is defined Flexible C-terminal phosphorylation deactivates melanopsin 5 105 as the region that includes P-I and P-II, while the distal C-terminus includes P-III, P-IV, and beyond. Figure   106 made using Protter (47).
107
108 RESULTS
109
Six Putative Phosphorylation Sites, P-II, Are Necessary but Insufficient to Deactivate Melanopsin 110 One approach employed by previous studies to identify critical sites of phosphorylation was the 111 mutation of predicted GRK phosphorylation sites on wild-type melanopsin. Here, we initially took a similar 112 approach by examining the importance of proximal C-terminus serine and threonine residues through 113 mutagenesis of clusters of six sites at a time ( Figure 1 ). Our data suggest that the first six serine and 114 threonine residues on the C-terminus, P-I (S372, S376, S379, S381, S384, T385), are not required to 
122
(13), where mutagenesis of those same six serine and threonine residues or their elimination via C-terminus 123 truncation resulted in prolonged melanopsin deactivation. We also synthesized melanopsin mutants where 124 the distally located putative sites of phosphorylation, P-III (S398, S401, S408, S411, S413, T418) and P-125 IV (T420, T422, T423, S433, S436, S439) (P-III Null and P-IV Null), were mutated to alanines. Mutation 126 of the P-III cluster produces a sizable and significant reduction in the deactivation rate of melanopsin, but 127 the extent of the reduction is less than the P-II mutant. Interestingly, mutation of the P-IV cluster also results 128 in a very slight, but significant defect in deactivation rate compared to wild-type melanopsin. These 129 experiments support the importance of the P-II cluster as the most functionally significant serine and 
143
We next employed an alternative approach to examine C-terminus phosphorylation: using the 144 phosphonull melanopsin mutant, select putative phosphorylation sites of interest were mutated back to the 145 serine or threonine residues as in wild-type mouse melanopsin. In doing so, we better describe which 146 phosphorylation sites are sufficient for the deactivation of melanopsin and also test which serines and 147 threonines are likely to be phosphorylated in wild-type melanopsin. First, we tested if P-II is sufficient to of melanopsin sequences made using Geneious software (48) .
164

P-II and Additional Putative Phosphorylation Sites in the Proximal Region of the C-terminus, P-I, are
165
Needed to Properly Deactivate Melanopsin
166
To determine how many phosphorylation sites are needed to deactivate melanopsin, more putative 167 phosphorylation sites were mutated from alanine to serine/threonine using the phosphonull +P-II mutant as 168 the starting template. While the most proximal cluster of six phosphorylation sites, P-I, are not required for
169 melanopsin deactivation, we tested if they played any functional role in this process ( Figure 3 ). We tested 170 a series of melanopsin phosphonull mutants in a calcium imaging assay using transiently transfected 171 HEK293 cells. Our findings suggest that at least eight of the proximal twelve possible phosphorylation sites 172 are needed to deactivate melanopsin ( Figure 3 ). Specifically, the required cluster, P-II, is needed in 173 conjunction with the proximal cluster P-I. Additional mutants tested (Supporting Figure 1 ) suggest that P-
174
I alone is also insufficient to deactivate melanopsin. Furthermore, putative phosphorylation sites in the 175 proximal cluster closer to P-II, particularly S384 and T385, deactivate melanopsin at a faster rate compared 176 to the proximal residues in this cluster (Supporting Figure 2 ).
178
P-II and Additional Putative Phosphorylation Sites Located Distally on the C-terminus can also
179 Deactivate Melanopsin
180
Truncation of mouse melanopsin's C-terminus after P-II or beyond produces no defect in 181 melanopsin's signaling kinetics when tested in a calcium imaging assay (13). This experiment suggests that there is no role of the distal C-terminus in regulating melanopsin deactivation, and therefore suggesting that 183 phosphorylation of the distal C-terminal amino acids is not necessary. Using a similar approach as the 184 previous experiments, we synthesized phosphonull mutants where P-II residues were mutated from alanine 185 to serine/threonine. Additionally, two clusters of six putative phosphorylation sites downstream on the C-186 terminus (P-III or P-IV, Figure 4 ) were also mutated in a similar manner. Expression and calcium imaging 187 of these mutants suggests that the distal C-terminus phosphorylation sites along with the P-II region can 188 indeed deactivate melanopsin ( Figure 4 ). Specifically, P-II and P-III deactivate melanopsin (Phosphonull 189 +P12 (P-II, P-III), Figure 4 ). Interestingly, analysis of the deactivation rate suggests that this mutant 190 deactivates melanopsin at a faster rate than wild-type melanopsin (Figure 4 ), suggesting once again that the Next, we tested if P-IV can also contribute to melanopsin deactivation by using the phosphonull 203 construct to mutate P-II and P-IV (Phosphonull +12 (P-II, P-IV), Figure 4 ) to serines and threonines. This 204 resulted in a moderate, yet significant improvement of the deactivation rate compared to phosphonull 205 ( Figure 4 ). However, these mutations were insufficient to fully deactivate melanopsin (Figure 4 ), suggesting 206 that the distal region of the C-terminus can indeed play a role in this process, but confirming that the To further test the importance of the phosphorylation sites' location in deactivating melanopsin, we 213 synthesized melanopsin C-terminus chimeras by fusing truncated melanopsin with the C-termini of β-214 adrenergic receptor or angiotensin II type-1a receptor. Melanopsin was truncated directly before P-II, at 215 residue R387, and the chimeric C-termini contain the important phosphorylation sites of their respective 216 receptors. In doing so, we further tested the importance of phosphorylation sites at the P-II region, which 217 is compensated for in the β-adrenergic receptor chimera ( Figure 5 ), but not in the angiotensin II type-1a 218 receptor ( Figure 5 ). This is due to the melanopsin-β-adrenergic receptor chimera containing 219 phosphorylation sites located immediately following the melanopsin truncation, and not so in the 220 melanopsin-angiotensin II type-1a receptor chimera. Upon testing these chimeras using calcium imaging,
221
the melanopsin-β-adrenergic receptor chimera showed signaling kinetics that closely mimics wild-type 222 melanopsin ( Figure 5 ). On the other hand, the melanopsin-angiotensin II type-1a receptor's deactivation 223 kinetics are much slower and keeps the chimeric receptor active for a prolonged duration ( Figure 5 ). This 224 further supports the idea that melanopsin requires serine and threonine residues at both the location of P-II,
225
and adjacent to it. 
Phospho-Mimetic Mutations in Phosphonull Melanopsin Do Not Rescue the Delayed Deactivation Rate
239
To further test the importance of proximal C-terminus phosphorylation sites, we designed a 240 phospho-mimetic mutant using phosphonull melanopsin as a template. P-I and P-II were mutated from 241 alanines to aspartic acids (phosphonull +P12 (P-ID, P-IID)) and tested using calcium imaging ( Figure 6 ).
242
Likely, deactivation of the phosphomimetic-mutated-phosphonull through phosphorylation-independent 243 and charge-based coupling to β-arrestin is predicted to occur as previously shown in the chemokine receptor 244 D6 (30). However, not only did the phosphomimetic mutant fail to rescue phosphonull melanopsin's 245 deactivation defect, the mutant displayed a modulated activation ( Figure 6 ). Specifically, it failed to reach 246 peak signaling intensity during the time course of the experiment, thus suggesting a reduced capability of 247 this mutant to activate the signaling transduction cascade, possibly through the formation of multiple salt 248 bridges involving the proximal region of the C-terminus due to the introduction of many charged residues.
249
Similar to the data in Figure 2a , the phosphomimetic data suggest other regulatory roles for the C-terminus 250 aside from signaling deactivation. Previous studies on melanopsin's C-terminus phosphorylation state have used mutagenesis to 262 propose the phosphorylation sites needed for melanopsin deactivation. Here, melanopsin-expressing 263 HEK293 cells were exposed to either 1 min or 30 min of white light, quenched, and melanopsin was then 264 affinity-purified for proteolytic digestion using trypsin or a trypsin/chymotrypsin combination (1 min light 265 and dark samples were subjected to in-gel tryptic digest and 30 min light samples were subjected to 266 trypsin/chymotrypsin digest in solution). Proteolytic digestion resulted in ~30-40% sequence coverage for 267 light-exposed melanopsin, the majority of which covers transmembrane helix 7 and the C-terminus 268 (Supporting Figure 3) . Specifically, we observed C-terminal sequence coverage at P-I, P-II, and partially at 269 P-III in 1 min light-exposed samples and we observed coverage at P-II, P-III, and P-IV in 30 min light-270 exposed samples. We observed low sequence coverage in the dark sample, with coverage only at P-I. We 
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suggesting phosphorylation of residues S274, S379/S381, S379/S381/Y382 (Figure 7A , B, and C), which 292 are located in the proximal region of the C-terminus (P-I). The second and third phosphopeptides' 293 phosphorylation sites could not be confidently assigned to a single amino acid(s), thus suggesting that both 294 S379 and S381 could potentially be the residues phosphorylated in the second phosphopeptide and S379, 295 S381, and Y382 could be phosphorylated in the third phosphopeptide. 317 and S411( Figure 7D and E) . These phosphorylated residues are in the P-III region of the C-terminus.
318
Interestingly, P-II and P-III result in the fastest deactivation kinetics of melanopsin ( Figure 4A ), faster even 319 than wild-type melanopsin. These results suggest a more defined role of the distal C-terminus in melanopsin 320 deactivation than shown previously based on C-terminally truncated constructs (13, 14).
321
We also analyzed melanopsin samples obtained from dark-adapted transfected HEK293 cells,
322
without any exposure to light. Mass spectrometric analysis of these samples identified one phosphopeptide 323 ( 376 SHPSLpSYR 383 ) which suggests phosphorylation at residue S381 in the dark ( Figure 7F ). This finding 324 is consistent with the previous results found in rat melanopsin using phosphoserine-specific antibodies 325 which detected phosphorylation at that S381 in the dark (19) . Recent efforts to describe the structures of GPCR complexes and their formation has provided 330 invaluable information about the molecular determinants necessary for binding and activation of signaling 331 molecules. Most relevant to this study is the body of structural work investigating GPCR-C-terminus 332 phosphorylation and its effect on arrestin recruitment, activation, and binding (32). We present here a model 333 of melanopsin in complex with β-arrestin-1 (Figure 8) to provide a structural model for the importance of (Figure 8 ). Furthermore, we predict that the distal portion of the tail (not depicted in Figure 8 ),
350
containing phosphorylatable residues after the proximal twelve sites, is less structured and ordered than the 351 proximal C-terminus, thus limiting its ability to interact with the positively-charged phosphorylation-352 detection regions on arrestin. However, our functional and mass spectrometric data (Figures 4 and 7) Flexible 
360
The mouse melanopsin C-terminus has a uniquely large number of potential phosphorylation sites.
361
Given our results reported here, we propose that melanopsin's C-terminus undergoes phosphorylation 362 modification on a larger number of serine and threonine residues, centered primarily on a cluster of six 363 sites, P-II (S388, T389, S391, S392, S394, S395), and additional phosphorylations of residues immediately 364 surrounding it (P-I or P-III). While our data suggests that very distal C-terminus serine and threonine 365 residues can deactivate melanopsin (P-IV), they do so at a reduced capability. We present data supporting 366 the importance of amino acids in P-II that can be phosphorylated and select residues adjacent to it in either 367 the proximal or distal direction, particularly S274, S379, S381, or Y382 after 1 min of light exposure, S408
368 and S411 during prolonged light exposure, and S381 in the dark. These data therefore suggest melanopsin's 369 C-terminus can exist in multiple light-dependent and dark-adapted phosphorylated states. This is not 370 unexpected due to the predicted extended and unstructured nature of the C-terminus (past residue 396). The
371
data presented here and past work (13, 14) suggest that deactivation is mediated by phosphorylation of 372 proximal and distal C-terminus phosphorylation sites. Additionally, two phosphorylation sites were 373 previously identified in rat melanopsin, S381 and S398, that are phosphorylated in the dark and light, 374 respectively (19) . Rather than suggesting that these data are contradictory, we propose that these data all 375 represent the various phosphorylation states of melanopsin's C-terminus. As our data suggest, various 376 phosphorylation states of the C-terminus contribute to signaling deactivation.
377
The relatively long C-terminus of melanopsin raises some interesting structural questions. To 378 mention a few, does the very distal region of the C-terminus, specifically, after residue S418, play any role in deactivating wild-type melanopsin? Our C-terminus mutant, Melanopsin +P12 (P-II, P-IV), suggests a 380 limited role of the distal region in the deactivation of melanopsin, but does phosphorylation of these serine 381 and threonine residues normally occur? We propose that distal putative phosphorylation sites can indeed 382 be phosphorylated, even though no phosphorylation at these sites was detected through mass spectroscopy.
383
Alternatively, there is the possibility that the serine and threonine residues in P-IV, and even in P-I, hold 384 structural significance rather than just serving as sites of phosphorylation. These sites, whether 385 phosphorylated or not, could help to maintain the C-terminus in a conformation that improves the 386 accessibility of critical binding regions (i.e. intracellular loops) though the formation of hydrogen bonds or 387 salt bridges at select serine and threonine residues on the C-terminus. Thus, this might be an interesting 388 mechanism involved in modulating signaling activity. Specifically, through altering the degree of steric 389 freedom at the melanopsin-signaling molecule complex interface.
390
Taking all this into account, we propose a model of melanopsin C-terminus functional versatility 391 where light-activation induces phosphorylation of the C-terminus at select residues on P-I, P-II, and P-III,
392
which produces signaling deactivation through arrestin activation and binding. Specifically, our findings 393 suggest that P-II is the initial region of phosphorylation, likely by GRK, and our findings also suggest that 394 additional phosphorylation occur on both P-I and P-III clusters. P-II phosphorylation also occurs very 395 rapidly and is tightly regulated (i.e. rapid de-phosphorylation kinetics), as we did not capture P-II 396 phosphorylation in 1 min of light exposure. Furthermore, P-III holds more importance for signal termination 397 than P-I, as evidenced by the profound effects on light responses after its mutagenesis. P-IV can also be 398 phosphorylated and have an impact on light response termination but holds the least functional significance 399 out of all examined clusters. Thus, the time frame of reactions is proposed to occur as follows: dark-adapted 400 melanopsin exists with P-I phosphorylation to prime the cytoplasmic conformation for G-protein activation.
401
Then, after light illumination, P-II is rapidly phosphorylated, followed by P-III and P-I phosphorylation,
402
and finally, phosphorylation of P-IV or distal sites. Simultaneous with these phosphorylation reactions,
403
there is rapid coupling of melanopsin to signaling molecules (i.e. G-protein and arrestin) and 404 simultaneously, there is rapid regulation of the phosphorylation state by de-phosphorylation of the most Flexible C-terminal phosphorylation deactivates melanopsin 21 405 critical cluster, P-II. P-III phosphorylation persists after prolonged light exposure, suggesting that these 406 sites also help regulate sustained light responses in addition to the rapid, initial deactivation response.
407
Additionally, phosphorylated serine and threonine residues throughout the C-terminus regulate formation 408 of signaling complexes and modulate melanopsin signaling at the level of the receptor.
409
While the P-II region is the most important and necessary cluster of potential phosphorylation sites,
410
we didn't observe phosphopeptides with phosphorylations in this region during any of our time points in 411 our mass spectrometric analysis. While unexpected, there is the possibility that phosphorylation of these 412 sites is much more transient than at the sites we observed at 1 min or 30 min. Phosphorylation of P-II could 413 be induced in a much more rapid timeframe as well, potentially immediately following light-activation of 414 melanopsin, and this would also raise the possibility of dephosphorylation kinetics being rapid as well.
415
Alternatively, the residues at P-II could serve as a binding site for either kinase or arrestin, instead of being 416 direct sites of phosphorylation. While our data implicates P-I, -II, -III, and -IV in the regulation of 417 melanopsin deactivation, it is also conceivable that some of these phosphorylations could be performing 418 alternative and undescribed function. Given the length of the C-terminus, it might be possible that 419 modification of very distal and unexplored residues could lead to interaction with binding partners that 420 remain to be elucidated.
421
We also propose that our data suggests interesting mechanisms used in ipRGC phototransduction, For 1-min and dark melanopsin samples, concentrated eluates were size separated through SDS-535 PAGE electrophoresis followed by Coomassie staining. After excising the desired bands, excised gel bands 536 were cut into approximately 1 mm 3 pieces. The samples were reduced with 1 mM DTT for 30 min at 60 ºC 537 and then alkylated with 5 mM iodoacetamide for 15 min in the dark at room temperature. Gel pieces were 538 then subjected to a modified in-gel trypsin digestion procedure (41) . Gel pieces were washed and 539 dehydrated with acetonitrile for 10 min. followed by removal of acetonitrile. Pieces were then completely 540 dried in a speed-vac. Rehydration of the gel pieces was with 50 mM ammonium bicarbonate solution 541 containing 12.5 ng/µl modified sequencing-grade trypsin (Promega) at 4 ºC. Samples were then placed in 542 a 37 ºC room overnight. Peptides were later extracted by removing the ammonium bicarbonate solution,
543
followed by one wash with a solution containing 50% acetonitrile and 1% formic acid. The extracts were 544 then dried in a speed-vac (~1 hr). The samples were then stored at 4 ºC until analysis. On the day of analysis, 545 the samples were reconstituted in 5-10 µl of HPLC solvent A (2.5% acetonitrile, 0.1% formic acid). A 546 nano-scale reverse-phase HPLC capillary column was created by packing 2.6 µm C18 spherical silica beads 547 into a fused silica capillary (100 µm inner diameter x ~30 cm length) with a flame-drawn tip. After 548 equilibrating the column each sample was loaded via a Famos auto sampler (LC Packings) onto the column.
549
A gradient was formed, and peptides were eluted with increasing concentrations of solvent B (97.5% 550 acetonitrile, 0.1% formic acid). Each peptide was eluted, subjected to electrospray ionization, and then 551 entered an LTQ Orbitrap Velos Pro ion-trap mass spectrometer (ThermoFisher Scientific). Eluting peptides 552 were detected, isolated, and fragmented to produce a tandem mass spectrum of specific fragment ions for 553 each peptide. Peptide sequences (and hence protein identity) were determined by matching protein or 554 translated nucleotide databases with the acquired fragmentation pattern by the software program Sequest 555 (ThermoFinnigan). The modification of 79.9663 mass units to serine, threonine, and tyrosine was included 556 in the database searches to determine phosphopeptides. Phosphorylation assignments were determined by 557 the Ascore algorithm (43). All databases include a reversed version of all sequences and the data were 558 filtered to between a one and two percent peptide false discovery rate.
